melanoma vaccine

Moderna shares surged 177% in a historic one-day rally, sending moderna stock sharply higher after the biotechnology company and Merck reported encouraging results from a late-stage trial of their personalized mRNA cancer vaccine. The dramatic jump came after the treatment showed significant benefits in helping prevent melanoma from returning and spreading, giving investors renewed confidence … Read more